Myths & Misconceptions - The Anticoagulation Debate

Join us as leading medical experts address common questions around novel oral anticoagulants (NOACs) in the series 'Myths and Misconceptions - The Anticoagulation Debate'.

After five decades of Vitamin K Antagonists for stroke prevention in non-valvular atrial fibrillation, NOACs were approved providing further anticoagulation options to patients and physicians alike.

However the anticoagulation journey for NOACs is ongoing and along the way there have been questions raised. Questions that our debates aim to address, on recent key topics including:
 

• Efficacy vs. safety
• Once or twice daily regimes